Cadre Holdings Reports Second Quarter 2022 Financial Results

Exceeds Pricing Growth Target Above Inflation, Generates Strong Adjusted EBITDA Conversion, and Increases Orders Backlog

Further Expands International Presence and Focus on High Margin Businesses with Strong Recurring Revenues and Cash Flows Following Second Accretive Acquisition Since IPO

Reaffirms 2022 Full-Year Guidance

JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Cadre Holdings, Inc. (NYSE: CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced today its consolidated operating results for the three and six months ended June 30, 2022.

Second Quarter and June 2022 Year-to-Date Highlights

  • Net sales of $118.2 million for the second quarter; net sales of $222.6 million for the six months ended June 30, 2022
  • Gross profit margin of 36.6% for the second quarter; gross profit margin of 37.5% for the six months ended June 30, 2022
  • Net income of $4.4 million, or $0.12 per diluted share, for the second quarter; net loss of $5.7 million, or $0.16 per diluted share, for the six months ended June 30, 2022
  • Adjusted EBITDA of $18.4 million for the second quarter; Adjusted EBITDA of $32.6 million for the six months ended June 30, 2022
  • Adjusted EBITDA margin of 15.6% for the second quarter; Adjusted EBITDA margin of 14.6% for the six months ended June 30, 2022
  • Adjusted EBITDA conversion of 92% for the second quarter; Adjusted EBITDA conversion of 92% for the six months ended June 30, 2022
  • Declared quarterly cash dividend of $0.08 per share in July 2022

“During the quarter, we took important steps to position Cadre to further enhance our leadership in providing mission-critical safety and survivability equipment, as we seek to create long-term shareholder value,” said Warren Kanders, CEO and Chairman. “During the quarter, and against a backdrop of ongoing supply chain disruptions, we exceeded our 1% pricing growth target above inflation, while drawing on our low Cap-Ex model to generate strong Adjusted EBITDA conversion. We also grew our orders backlog, as demand for our trusted products remains strong, and we continue to expect our product portfolio mix to normalize in the second half of 2022. Our entrenched positions in law enforcement, first responder and military markets continue to serve us well, and we remain focused on further implementing our resilient and proven operating model aimed at creating significant value for customers and all Cadre stakeholders, as well as driving margin expansion over the long term.”

Mr. Kanders added, “We continue to draw on our strong cash flow to capitalize on attractive opportunities, and during the second quarter we further enhanced our liquidity position with an oversubscribed secondary offering. Complementing our core organic growth initiatives, we maintain a robust acquisition pipeline and are poised to build on our significant progress to date. We are pleased with the efficient integration of the two acquisitions since our IPO, and we continue to actively evaluate and are excited about additional opportunities, consistent with our focus on high margin companies with leading market positions and strong recurring revenues and cash flows.”

Second Quarter and June 2022 Year-to-Date Operating Results

For the quarter ended June 30, 2022, Cadre generated net sales of $118.2 million, as compared to $114.6 million for the quarter ended June 30, 2021. The increase was primarily the result of recent acquisitions and increased armor demand.

For the six months ended June 30, 2022, Cadre generated net sales of $222.6 million, as compared to $225.1 million for the prior year period mainly driven by prior year US Federal and crowd control shipments.

For the quarter ended June 30, 2022, Cadre generated gross profit of $43.2 million, as compared to $48.2 million for the quarter ended June 30, 2021. For the six months ended June 30, 2022, Cadre generated gross profit of $83.4 million, as compared to $92.2 million for the prior year period.

Gross profit margin was 36.6% for the quarter ended June 30, 2022, as compared to 42.1% for the quarter ended June 30, 2021, mainly driven by amortization of inventory step-up of 101 basis points and less favorable portfolio mix, partially offset by pricing in excess of material inflation.

Gross profit margin was 37.5% for the six months ended June 30, 2022, as compared to 41.0% for the prior year period, mainly driven by amortization of inventory step-up of 60 basis points and less favorable portfolio mix, partially offset by pricing in excess of material inflation.

Net income was $4.4 million for the quarter ended June 30, 2022, as compared to net income of $6.8 million for the quarter ended June 30, 2021. The decrease resulted primarily from increased stock-based compensation expense, losses on foreign currency transactions and discrete acquisition-related expenses, partially offset by increased revenue.

Net loss was $5.7 million for the six months ended June 30, 2022, as compared to net income of $13.7 million for the prior year period, primarily as a result of increased stock-based compensation expense.

Cadre generated $18.4 million of Adjusted EBITDA for the quarter ended June 30, 2022, as compared to $20.5 million for the quarter ended June 30, 2021. Adjusted EBITDA margin was 15.6% for the quarter ended June 30, 2022, as compared to 17.9% for the prior year period.

Cadre generated $32.6 million of Adjusted EBITDA for the six months ended June 30, 2022, as compared to $40.7 million for the prior year period. Adjusted EBITDA margin was 14.6% for the six months ended June 30, 2022, as compared to 18.1% for the prior year period.

Product segment gross margin was 39.0% and 39.5% for the second quarter and first half of 2022, respectively, compared to 43.5% and 42.1% for the respective prior year periods.

Distribution segment gross margin was 18.2% and 21.4% for the second quarter and first half of 2022, respectively, compared to 25.5% and 25.4% for the respective prior year periods.

Liquidity, Cash Flows and Capital Allocation

  • Cash and cash equivalents decreased by $5.0 million from $33.9 million as of December 31, 2021 to $28.9 million as of June 30, 2022.
  • Total debt decreased by $7.1 million from $159.7 million as of December 31, 2021, to $152.6 million as of June 30, 2022.
  • Net debt (total debt net of cash and cash equivalents) decreased by $2.1 million from $125.8 million as of December 31, 2021, to $123.7 million as of June 30, 2022.
  • Capital expenditures totaled $1.4 million for the second quarter and $2.5 million for the six months ended June 30, 2022, compared with $0.7 million for the second quarter and $1.5 million for the six months ended June 30, 2021.

Secondary Offering

On June 9, 2022, Cadre completed a secondary offering in which the Company issued and sold 2,250,000 shares of common stock at a price of $23.50 per share, resulting in net proceeds to the Company of $47.0 million after underwriter discounts and commissions, fees and expenses.

On July 14, 2022, the underwriters exercised a portion of their over-allotment option and purchased an additional 300,000 shares of common stock at a price of $23.50 per share, resulting in net proceeds to the Company of $6.6 million after underwriter discounts and commissions, fees and expenses.

Acquisition of Cyalume Technologies

On May 5, 2022, Cadre announced the completion of its accretive acquisition of Cyalume Technologies, a leading manufacturer of proprietary chemical illumination solutions for military, first responder and other commercial applications. The purchase price for the acquisition was $35.7 million, net of cash acquired, subject to customary adjustments for net working capital, transaction expenses and indebtedness, and was funded through a draw on its existing credit facilities.

Dividend

On July 20, 2022, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.08 per share, or $0.32 per share on an annualized basis. Cadre's dividend payment will be made on August 12, 2022, to shareholders of record as of the close of business on the record date of August 1, 2022. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.

2022 Outlook

For the full year 2022, Cadre expects to generate net sales in the range of $444.0 million to $452.0 million and Adjusted EBITDA in the range of $72.5 million and $77.5 million. Cadre expects Adjusted EBITDA conversion in the range of 92-95% for the full year.

Conference Call

Cadre management will host a conference call on Thursday, August 11, 2022, at 5:00 PM EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (888)-510-2553 and the dial-in number for international callers is 646-960-0473. The access code for all callers is 1410384. A live webcast will also be available on the Company’s website at https://www.cadre-holdings.com/.

A replay of the call will be available through August 25, 2022. To access the replay, please dial 800-770-2030 in the U.S. or +1-647-362-9199 if outside the U.S., and then enter the access code 1410384.

About Cadre

Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety and survivability products for first responders. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, and duty gear. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.

Use of Non-GAAP Measures

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization (“EBITDA”), (ii) adjusted EBITDA, (iii) adjusted EBITDA margin, (iv) adjusted EBITDA conversion rate and (v) LTM adjusted EBITDA. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user’s overall understanding of the Company’s current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company’s reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

Forward-Looking Statements

Except for historical information, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include but are not limited to all projections and anticipated levels of future performance. Forward-looking statements involve risks, uncertainties and other factors that may cause our actual results to differ materially from those discussed herein. Any number of factors could cause actual results to differ materially from projections or forward-looking statements, including without limitation, changes to global, social and political economic conditions, spending patterns of government agencies, competitive pressures, the impact of acquisitions and related integration activities, logistical challenges related to disruptions and delays, product liability claims, the success of new product introductions, currency exchange rate fluctuations and the risks of doing business in the markets in which we operate, including foreign countries. More information on potential factors that could affect the Company’s financial results are more fully described from time to time in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release, and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release.

CADRE HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share amounts)

 

 

 

 

 

 

 

 

 

June 30, 2022

 

December 31, 2021

Assets

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash and cash equivalents

 

$

28,862

 

 

$

33,857

 

Accounts receivable, net of allowance for doubtful accounts of $817 and $645, respectively

 

 

56,521

 

 

 

48,344

 

Inventories

 

 

76,630

 

 

 

63,978

 

Prepaid expenses

 

 

6,932

 

 

 

10,353

 

Other current assets

 

 

5,956

 

 

 

3,171

 

Assets held for sale

 

 

251

 

 

 

278

 

Total current assets

 

 

175,152

 

 

 

159,981

 

Property and equipment, net of accumulated depreciation and amortization of $40,111 and $37,171, respectively

 

 

46,997

 

 

 

33,053

 

Deferred tax assets, net

 

 

8,133

 

 

 

7,059

 

Intangible assets, net

 

 

55,177

 

 

 

42,415

 

Goodwill

 

 

78,027

 

 

 

66,262

 

Other assets

 

 

5,990

 

 

 

3,026

 

Total assets

 

$

369,476

 

 

$

311,796

 

 

 

 

 

 

 

 

Liabilities, Mezzanine Equity and Shareholders' Equity

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

Accounts payable

 

$

29,145

 

 

$

19,328

 

Accrued liabilities

 

 

35,896

 

 

 

40,736

 

Income tax payable

 

 

918

 

 

 

1,255

 

Liabilities held for sale

 

 

106

 

 

 

128

 

Current portion of long-term debt

 

 

10,321

 

 

 

13,174

 

Total current liabilities

 

 

76,386

 

 

 

74,621

 

Long-term debt

 

 

142,244

 

 

 

146,516

 

Deferred tax liabilities

 

 

3,589

 

 

 

1,297

 

Other liabilities

 

 

959

 

 

 

722

 

Total liabilities

 

 

223,178

 

 

 

223,156

 

 

 

 

 

 

 

 

Mezzanine equity

 

 

 

 

 

 

Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2022 and December 31, 2021)

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders' equity

 

 

 

 

 

 

Common stock ($0.0001 par value, 190,000,000 shares authorized, 37,032,271 and 34,383,350 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively)

 

 

4

 

 

 

3

 

Additional paid-in capital

 

 

194,704

 

 

 

127,606

 

Accumulated other comprehensive loss

 

 

(105

)

 

 

(1,917

)

Accumulated deficit

 

 

(48,305

)

 

 

(37,052

)

Total shareholders’ equity

 

 

146,298

 

 

 

88,640

 

Total liabilities, mezzanine equity and shareholders' equity

 

$

369,476

 

 

$

311,796

 

CADRE HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except share and per share amounts)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2022

 

2021

 

2022

 

2021

Net sales

 

$

118,232

 

 

$

114,561

 

 

$

222,638

 

 

$

225,097

 

Cost of goods sold

 

 

75,011

 

 

 

66,333

 

 

 

139,228

 

 

 

132,910

 

Gross profit

 

 

43,221

 

 

 

48,228

 

 

 

83,410

 

 

 

92,187

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

32,749

 

 

 

31,444

 

 

 

86,699

 

 

 

59,495

 

Restructuring and transaction costs

 

 

1,203

 

 

 

1,219

 

 

 

1,802

 

 

 

1,540

 

Related party expense

 

 

1,112

 

 

 

142

 

 

 

1,234

 

 

 

295

 

Total operating expenses

 

 

35,064

 

 

 

32,805

 

 

 

89,735

 

 

 

61,330

 

Operating income (loss)

 

 

8,157

 

 

 

15,423

 

 

 

(6,325

)

 

 

30,857

 

Other expense

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(1,439

)

 

 

(5,621

)

 

 

(2,929

)

 

 

(10,665

)

Other expense, net

 

 

(756

)

 

 

(485

)

 

 

(961

)

 

 

(529

)

Total other expense, net

 

 

(2,195

)

 

 

(6,106

)

 

 

(3,890

)

 

 

(11,194

)

Income (loss) before provision for income taxes

 

 

5,962

 

 

 

9,317

 

 

 

(10,215

)

 

 

19,663

 

(Provision) benefit for income taxes

 

 

(1,517

)

 

 

(2,502

)

 

 

4,495

 

 

 

(5,984

)

Net income (loss)

 

$

4,445

 

 

$

6,815

 

 

$

(5,720

)

 

$

13,679

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.13

 

 

$

0.25

 

 

$

(0.16

)

 

$

0.50

 

Diluted

 

$

0.12

 

 

$

0.25

 

 

$

(0.16

)

 

$

0.50

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

35,320,314

 

 

 

27,483,350

 

 

 

34,888,703

 

 

 

27,483,350

 

Diluted

 

 

35,688,620

 

 

 

27,483,350

 

 

 

34,888,703

 

 

 

27,483,350

 

CADRE HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

Six Months Ended June 30,

 

 

2022

 

2021

Cash Flows From Operating Activities:

 

 

 

 

 

 

Net (loss) income

 

$

(5,720

)

 

$

13,679

 

Adjustments to reconcile net (loss) income to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

7,380

 

 

 

7,020

 

Amortization of original issue discount and debt issue costs

 

 

367

 

 

 

2,029

 

Amortization of inventory step-up

 

 

1,344

 

 

 

 

Deferred income taxes

 

 

(4,594

)

 

 

4,607

 

Stock-based compensation

 

 

26,327

 

 

 

 

Provision for (recoveries from) losses on accounts receivable

 

 

240

 

 

 

(308

)

Foreign exchange loss

 

 

1,107

 

 

 

(267

)

Changes in operating assets and liabilities, net of impact of acquisitions:

 

 

 

 

 

 

Accounts receivable

 

 

(3,243

)

 

 

(2,429

)

Inventories

 

 

(1,461

)

 

 

(7,124

)

Prepaid expenses and other assets

 

 

3,616

 

 

 

2,292

 

Accounts payable and other liabilities

 

 

(345

)

 

 

9,208

 

Net cash provided by operating activities

 

 

25,018

 

 

 

28,707

 

Cash Flows From Investing Activities:

 

 

 

 

 

 

Purchase of property and equipment

 

 

(2,473

)

 

 

(1,506

)

Business acquisitions, net of cash acquired

 

 

(55,039

)

 

 

 

Net cash used in investing activities

 

 

(57,512

)

 

 

(1,506

)

Cash Flows From Financing Activities:

 

 

 

 

 

 

Proceeds from revolving credit facilities

 

 

48,000

 

 

 

176,548

 

Principal payments on revolving credit facilities

 

 

(48,000

)

 

 

(176,548

)

Principal payments on term loans

 

 

(5,009

)

 

 

(13,687

)

Principal payments on insurance premium financing

 

 

(2,853

)

 

 

(1,225

)

Payment of capital leases

 

 

(22

)

 

 

(21

)

Taxes paid in connection with employee stock transactions

 

 

(6,216

)

 

 

 

Proceeds from secondary offering, net of underwriter discounts

 

 

49,703

 

 

 

 

Deferred offering costs

 

 

(2,715

)

 

 

 

Dividends distributed

 

 

(5,533

)

 

 

 

Net cash provided by (used in) financing activities

 

 

27,355

 

 

 

(14,933

)

Effect of foreign exchange rates on cash and cash equivalents

 

 

144

 

 

 

42

 

Change in cash and cash equivalents

 

 

(4,995

)

 

 

12,310

 

Cash and cash equivalents, beginning of period

 

 

33,857

 

 

 

2,873

 

Cash and cash equivalents, end of period

 

$

28,862

 

 

$

15,183

 

Supplemental Disclosure of Cash Flows Information:

 

 

 

 

 

 

Cash paid for income taxes, net

 

$

241

 

 

$

473

 

Cash paid for interest

 

$

2,330

 

 

$

8,524

 

Supplemental Disclosure of Non-Cash Investing and Financing Activities:

 

 

 

 

 

 

Accruals and accounts payable for capital expenditures

 

$

17

 

 

$

 

CADRE HOLDINGS, INC.

SEGMENT INFORMATION

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended June 30, 2022

 

 

 

 

 

 

 

 

Reconciling

 

 

 

 

 

Products

 

Distribution

 

Items(1)

 

Total

Net sales

 

$

185,223

 

$

47,824

 

$

(10,409

)

 

$

222,638

Cost of goods sold

 

 

112,067

 

 

37,578

 

 

(10,417

)

 

 

139,228

Gross profit

 

$

73,156

 

$

10,246

 

$

8

 

 

$

83,410

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended June 30, 2021

 

 

 

 

 

 

 

 

Reconciling

 

 

 

 

 

Products

 

Distribution

 

Items(1)

 

Total

Net sales

 

$

190,121

 

$

47,579

 

$

(12,603

)

 

$

225,097

Cost of goods sold

 

 

110,028

 

 

35,476

 

 

(12,594

)

 

 

132,910

Gross profit

 

$

80,093

 

$

12,103

 

$

(9

)

 

$

92,187

CADRE HOLDINGS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended

 

Three Months

 

Three Months Ended

 

Six Months Ended

 

Last Twelve

 

 

 

December 31,

 

Ended March 31,

 

June 30,

 

June 30,

 

Months

 

 

 

2021

 

2022

 

2022

 

2021

 

2022

 

2021

 

June 30, 2022

 

Net income (loss)

 

$

12,661

 

 

$

(10,165

)

 

$

4,445

 

 

$

6,815

 

 

$

(5,720

)

 

$

13,679

 

 

$

(6,738

)

 

Add back:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

13,718

 

 

 

3,544

 

 

 

3,836

 

 

 

3,481

 

 

 

7,380

 

 

 

7,020

 

 

 

14,078

 

 

Interest expense

 

 

16,425

 

 

 

1,490

 

 

 

1,439

 

 

 

5,621

 

 

 

2,929

 

 

 

10,665

 

 

 

8,689

 

 

Provision (benefit) for income taxes

 

 

6,531

 

 

 

(6,012

)

 

 

1,517

 

 

 

2,502

 

 

 

(4,495

)

 

 

5,984

 

 

 

(3,948

)

 

EBITDA

 

$

49,335

 

 

$

(11,143

)

 

$

11,237

 

 

$

18,419

 

 

$

94

 

 

$

37,348

 

 

$

12,081

 

 

Add back:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring and transaction costs(1)

 

 

3,430

 

 

 

599

 

 

 

2,203

 

 

 

1,219

 

 

 

2,802

 

 

 

1,540

 

 

 

4,692

 

 

Loss on extinguishment of debt(2)

 

 

15,155

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15,155

 

 

Other expense, net(3)

 

 

947

 

 

 

205

 

 

 

756

 

 

 

485

 

 

 

961

 

 

 

529

 

 

 

1,379

 

 

Stock-based compensation expense(4)

 

 

355

 

 

 

23,723

 

 

 

2,818

 

 

 

 

 

 

26,541

 

 

 

 

 

 

26,896

 

 

Stock-based compensation payroll tax expense(5)

 

 

 

 

 

298

 

 

 

7

 

 

 

 

 

 

305

 

 

 

 

 

 

305

 

 

LTIP bonus(6)

 

 

2,162

 

 

 

384

 

 

 

174

 

 

 

328

 

 

 

558

 

 

 

1,280

 

 

 

1,440

 

 

Amortization of inventory step-up(7)

 

 

 

 

 

153

 

 

 

1,191

 

 

 

 

 

 

1,344

 

 

 

 

 

 

1,344

 

 

Adjusted EBITDA

 

$

71,384

 

 

$

14,219

 

 

$

18,386

 

 

$

20,451

 

 

$

32,605

 

 

$

40,697

 

 

$

63,292

 

 

Less: Capital expenditures

 

 

(3,029

)

 

 

(1,069

)

 

 

(1,421

)

 

 

(718

)

 

 

(2,490

)

 

 

(1,506

)

 

 

(4,013

)

 

Adjusted EBITDA less capital expenditures

 

$

68,355

 

 

$

13,150

 

 

$

16,965

 

 

$

19,733

 

 

$

30,115

 

 

$

39,191

 

 

$

59,279

 

 

Adjusted EBITDA conversion rate(8)

 

 

96

 

%

 

92

 

%

 

92

 

%

 

96

 

%

 

92

 

%

 

96

 

%

 

94

 

%

Adjusted EBITDA margin(9)

 

 

16.7

 

%

 

13.6

 

%

 

15.6

 

%

 

17.9

 

%

 

14.6

 

%

 

18.1

 

%

 

 

 

 

Gray Hudkins
Cadre Holdings, Inc.
203-550-7148
gray.hudkins@cadre-holdings.com

Investor Relations:
The IGB Group
Leon Berman / Matt Berkowitz
212-477-8438 / 212-227-7098
lberman@igbir.com / mberkowitz@igbir.com

Media Contact:
Jonathan Keehner / Andrew Siegel
Joele Frank, Wilkinson Brimmer Katcher
212-355-4449

Source: Cadre Holdings, Inc.